-
2024-513054-30-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2024-511346-39-00
3
2025-03-28
Immune-mediated necrotizing myopathy
-
2024-515451-38-00
5
2025-02-27
Primary Immune thrombocytopenia (ITP)
-
2022-501332-42-00
5
2025-02-26
Relapsing Remitting Multiple Sclerosis
-
2023-503630-44-00
10
2024-11-20
Treatment of moderate-to-severe Atopic dermatitis
-
2023-506235-15-00
5
2024-11-07
Limited-Stage Small-Cell Lung Cancer (LS SCLC)
-
2023-504358-36-00
5
2024-10-17
multiple sclerosis
-
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
-
2022-501105-12-00
5
2024-07-15
Urothelial Carcinoma
-
2023-503699-25-00
5
2024-07-15
Progressive Pulmonary Fibrosis
-
2022-502548-12-00
5
2023-09-28
marginal zone lymphoma
-
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2025-522046-42-00
5
2026-03-24
Colonic disease
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)
-
2025-522683-32-00
5
2026-01-15
Early-Stage Parkinson’s Disease (PD)
-
2025-522026-13-00
4
2026-01-12
Obsessive compulsive disorder
-
2024-520164-33-00
5
2025-12-09
Non-Small Cell Lung Cancer
-
2025-520730-28-00
4
2025-12-08
Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis